InsiderFlow

Peter Ordentlich

SNDX

Peter Ordentlich serves as Chief Scientific Officer at Syndax Pharmaceuticals, Inc. (SNDX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

5 trades

$1.92M

Net Position

Net Seller

$1.92M

Companies Traded

1

SNDX

Active Period

Feb 2022 – Feb 2023

5 total trades

Most Recent

Sell SNDX

Feb 17, 2023 · $646.1K

Peter Ordentlich's Insider Trading at Syndax Pharmaceuticals, Inc. (SNDX)

Buys

0 · $0.00

Sells

5 · $1.92M

Total Shares Bought

0

Total Shares Sold

76,481

SNDX Price Chart
Loading chart...
DateTypeValue
Feb 17, 2023 Sell$646.1K
Feb 3, 2023 Sell$2.0K
Dec 2, 2022 Sell$626.0K
Aug 26, 2022 Sell$625.9K
Feb 3, 2022 Sell$23.5K